Trials / Recruiting
RecruitingNCT07446153
A Clinical Study of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
An Open Label, Multicenter Phase I/II Clinical Study on the Safety, Tolerability, Pharmacokinetics, and Efficacy of HRS-8364 in the Treatment of Advanced Solid Tumor Subjects
- Status
- Recruiting
- Phase
- Phase 1 / Phase 2
- Study type
- Interventional
- Enrollment
- 282 (estimated)
- Sponsor
- Jiangsu HengRui Medicine Co., Ltd. · Industry
- Sex
- All
- Age
- 18 Years – 75 Years
- Healthy volunteers
- Not accepted
Summary
This study is an open, multicenter, Phase I/II clinical trial, divided into three stages: dose escalation, dose expansion and efficacy expansion.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | HRS-8364 Tablet | HRS-8364 tablet. |
Timeline
- Start date
- 2026-03-19
- Primary completion
- 2028-12-01
- Completion
- 2029-12-01
- First posted
- 2026-03-03
- Last updated
- 2026-04-03
Locations
2 sites across 1 country: China
Source: ClinicalTrials.gov record NCT07446153. Inclusion in this directory is not an endorsement.